Data strategies serve as a foundational framework for organisations to optimise their data operations and drive business success. By establishing a clear vision, these strategies guide the collection, storage, and utilisation of data to align with overarching business objectives. This structured approach not only accelerates decision-making through timely access to relevant information but also ensures the efficient allocation of resources.
Crucially, data strategies play a pivotal role in maintaining a competitive edge. They facilitate the development of data-driven products and services, fostering innovation and scalability. By embracing new technologies and analytics methods, organisations can adapt to changing market dynamics and position themselves as industry leaders.
Additionally, data strategies incorporate robust governance and security measures to mitigate risks associated with data breaches and regulatory compliance. They also emphasise customer-centric approaches, utilising data insights to understand and personalise products.
In essence, data strategies are indispensable tools that empower organisations to navigate the complex landscape of data, ensuring they not only keep pace with technological advancements but also proactively leverage their data assets for sustained success.
However, due to diverse reasons we see that many companies struggle to bring their data strategies to life: Their data endeavors are not linked closely to business ambitions, cultural gaps are not anticipated, their technology stack does not support their goals, etc. To address exactly these points, PwC has developed a comprehensive data strategy framework that allows your company to develop a holistic data strategy and successfully adopt it.
Looking at the setup of most pharmaceutical companies, their operational diversity becomes apparent: Besides core functions such as R&D, manufacturing, or commercial operations, they typically have a wide range of specialised support functions. To truly capture the value of data across the different departments, pharmaceutical companies need to consider their unique requirements and objectives and hence, need their own data strategy priorities. However, these priorities can evolve over time making a data strategy an ever-evolving piece.
While individual data strategies should exist in different business functions and areas, they need to be aligned across the firm which underlines the importance of a joint data vision that supports business goals. Business strategy considerations of a pharmaceutical company such as a focus on Research & Development, Mergers & Acquisitions, or a specific therapeutic area strongly influence the overall data vision and hence, trickle down on the data strategies of individual departments and corporate functions.
Throughout recent projects in the pharmaceutical industry, we saw our clients moving their technical infrastructure to one globally standardised and harmonised platform across different corporate functions such as commercial or manufacturing. This provides companies with multiple benefits in terms of scalability and efficiency:
• Along with standardising a data platform, companies usually perform a harmonisation of processes which accounts for efficiency gains
• Future upgrades or transformations of the data infrastructure are streamlined
• Reporting, analyses, and new insights are enabled through a globally aligned data foundation
• Skill transfer and flexibility in data governance archetypes build on top of a well-designed data platform
However, to make use of the full potential of implementing one data platform in a pharmaceutical company, it needs to be aligned with overarching data strategy considerations.
Are you ready to adopt the data strategy standards that are set by globally leading pharmaceutical companies? Get in touch with us to explore options of how your data strategy supports your business goals.
Joscha Milinski